Elmind Capital, LP Q4 2025 Filing

Filed February 17, 2026

Portfolio Value

$338.9M

Holdings

34

Report Date

Q4 2025

Filing Type

13F-HR

All Holdings (34 positions)

#StockSharesValue% PortfolioType
1
COGTCOGENT BIOSCIENCES INC
1,170,740$41.6M12.27%
2
SNDXSYNDAX PHARMACEUTICALS INC
1,855,000$39.0M11.50%
3
VRDNVIRIDIAN THERAPEUTICS INC
858,631$26.7M7.89%
4
VERAVERA THERAPEUTICS INC
482,500$24.4M7.21%
5
TCE2CELLDEX THERAPEUTICS INC NEW
865,000$23.5M6.93%
6
CGONCG ONCOLOGY INC
492,500$20.4M6.03%
7
BCRXBIOCRYST PHARMACEUTICALS INC
2,150,000$16.8M4.95%
8
PCVXVAXCYTE INC
291,500$13.4M3.97%
9
BEAMBEAM THERAPEUTICS INC
476,338$13.2M3.90%
10
PHVSPHARVARIS N V
475,750$13.2M3.90%
11
KALVKALVISTA PHARMACEUTICALS INC
801,300$12.9M3.82%
12
DVAXDYNAVAX TECHNOLOGIES CORP
679,900$10.5M3.09%
13
TYRATYRA BIOSCIENCES INC
350,000$9.2M2.72%
14
NRIXNURIX THERAPEUTICS INC
460,000$8.7M2.58%
15
WVEWAVE LIFE SCIENCES LTD
447,846$7.6M2.25%
16
MBXMBX BIOSCIENCES INC
211,000$6.7M1.96%
17
KRYSKRYSTAL BIOTECH INC
22,000$5.4M1.60%
18
UTHUNITED THERAPEUTICS CORP DEL
11,000$5.4M1.58%
19
BMRNBIOMARIN PHARMACEUTICAL INC
82,000$4.9M1.44%
20
RLAYRELAY THERAPEUTICS INC
536,946$4.5M1.34%
21
TVTXTRAVERE THERAPEUTICS INC
110,000$4.2M1.24%
22
PTGXPROTAGONIST THERAPEUTICS INC
38,000$3.3M0.98%
23
CGEMCULLINAN THERAPEUTICS INC
310,000$3.2M0.95%
24
LQDALIQUIDIA CORPORATION
90,000$3.1M0.92%
25
CTMXCYTOMX THERAPEUTICS INC
700,000$3.0M0.88%
26
URGNUROGEN PHARMA LTD
100,000$2.3M0.69%
27
IMCRIMMUNOCORE HLDGS PLC
58,248$2.0M0.60%
28
DSGNDESIGN THERAPEUTICS INC
207,900$1.9M0.58%
29
ENGNENGENE HOLDINGS INC
210,000$1.9M0.56%
30
ALECALECTOR INC
900,000$1.4M0.41%
31
AMLXAMYLYX PHARMACEUTICALS INC
112,000$1.4M0.40%
32
APLSAPELLIS PHARMACEUTICALS INC
50,000$1.3M0.37%
33
SUPNSUPERNUS PHARMACEUTICALS INC
20,000$994K0.29%
34
EWTXEDGEWISE THERAPEUTICS INC
30,000$744K0.22%